Center of Excellence in Engineered Cell Therapy for Cartilage Regeneration Research
Principal Investigator
Prof. Niket Kaisare
Objective
- This proposal seeks CSR support for infrastructure development and operational expenses required to run the Research facility. The support will facilitate the purchase of state-of-the-art equipment, empowering researchers to develop novel and advanced therapies to treat and reverse diseases associated with cartilage degeneration, such as Osteoarthritis.
Description
- Cartilage degeneration leads to chronic joint diseases, including Osteoarthritis (OA), causing significant disability worldwide, especially among older adults and women., Despite the enormous disease burden, there are currently no approved disease-modifying drugs., Engineered cells capable of synthesizing cartilage components that can rapidly regenerate full-thickness cartilage after a single administration, eliminating the need for surgical options, will ultimately make the vision of rapid, durable, and efficient cartilage regeneration a reality.
Impact
- A non-invasive, one-time therapeutic intervention will drastically improve patient outcomes and quality of life., Advancements in cell therapy will lead to increased collaboration between academia and industry., The research findings will contribute to policymaking on engineered cell and gene therapies to treat multiple diseases.
Budget in Lakhs
12.00